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The hallmark of diabetes is the presence of hyperglycemia. In contrast to acute 
hyperglycemia, chronic hyperglycemia impairs the secretion of insulin and contributes 
to insulin resistance and thereby perpetuates the diabetic disease. These damaging 
effects have been referred to as glucotoxicity, the cellular mechanisms of which are 
only partly understood. Amongst others inflammatory cytokines and oxidative stress 
seem to play an important role.  
The concept of glucotoxicity is very important to understand because immediate 
treatment may reverse the negative effects of glucose and increase the chance of 
remission. Remission, which is defined as normalisation of blood glucose and 
fructosamine levels and resolution of clinical signs and glucosuria without further 
need of antidiabetic therapy, usually occurs within the first 3 months after initiating 
therapy. Up till now no tests have been established suitable to predict remission. 
Insulin concentrations (baseline levels as well as after IV glucagon or IV arginine) are 
usually low at the time of diagnosis because of the suppressive effects of glucose 
(1,2). Therefore, the appropriate approach is to aim for optimal metabolic control. 
Intermediate-acting insulins are insulins of first choice in cats with uncomplicated 
diabetes. A porcine derived lente-type insulin (Caninsulin) is licensed for use in cats 
in many countries and probably the insulin most often used. In some cats duration of 
insulin action is less than 12 hours, an additional issue is that insulin absorption may 
be inconsistent causing erratic blood glucose concentrations. In human diabetics the 
same problem exists, which has led to the recent development of insulin analogs. 
Insulin glargine (Lantus) is currently the most frequently used long-acting insulin 
analog. In cats the duration of action is longer for glargine than for lente-type insulins, 
however, duration is usually less than 24 hours and glycemic control is better when 
given twice daily instead of once daily (3). Insulin glargine may be a suitable 
alternative for cats in which duration of action of lente-type insulin is too short for 
metabolic control. It has been postulated that the remission rate is higher in cats 
treated with insulin glargine than with other types of insulin. Although our own results 
also showed an advantage of glargine (4) the number of published cases is still too 
small to allow a definitive conclusion.  
Initial dosage (Caninsulin, Lantus) in cats weighing < 4 kg is 1 U/cat given twice daily, 
cats weighing > 4 kg usually receive 1.5 – 2.0 U/cat twice daily. In cats which have a 
blood glucose concentration < 20 mmol/l at the time of diagnosis, no more than 1 
U/cat twice daily independent of the body weight is given.  
The cat may be hospitalized for 1 – 2 days until work-up is completed. Blood glucose 
is measured 3 – 4 times throughout the day, insulin dosage should be reduced if 
hypoglycemia is detected (glucose < 5 mmol/l). Initial work-up and the begin of 
treatment may also be started on an outpatient basis.  
The cat is a true carnivore which distinguishes it clearly from the omnivorous dog. 
The natural diet of wild felids such as mice and birds contains less than 10% of 
carbohydrates on a dry matter basis. Using low-carbohydrate-high-protein diet results 
in better clinical control and increased rates of diabetic remission (5). Time of feeding 
relative to the insulin administration does not seem to play a role, the quality of 
metabolic control in cats receiving their meal together with the insulin injection is not 
different from cats which are fed 45 minutes after insulin administration (3). The 
feeding schedule should, however, be consistent from day to day, either two equal 
size meals around the time of insulin administration or “nibbling” throughout day and 
night.  
Frequent re-evaluations and amendments of insulin dosage are essential to increase 
the chance of diabetic remission. In our hospital re-evaluations are performed 
1,3,8,12 weeks after diagnosis and then approximately every 4 months. In most cats 
remission occurs during the first 3 months of therapy, if improvement of glycemic 
control or diabetic remission happen unnoticed serious hypoglycaemia may result. 
Ideally, fasting blood glucose (before the insulin injection) should be between 12-15 
mmol/l and the nadir 5-9 mmol/l. Dosage changes are performed with increments of 
0.5 U/cat BID approximately every 5 – 7 days. With this treatment regimen the 
current remission rate in our hospital is approximately 50%. Interestingly older cats 
have a greater chance of remission than younger cats (4). 
 
We are currently exploring the effect of tight glycemic control during the first week 
after diagnosis of diabetes mellitus. The protocol includes continuous intravenous 
infusion of crystalline insulin and monitoring of interstitial glucose concentration with a 
continuous glucose monitoring system (Guardian REAL-time CGMS). We 
hypothesize that tight control of blood glucose levels is crucial for functional recovery 
of beta-cells in the early clinical stage of the disease. Preliminary results show that 
cats that started with the intensive insulin protocol are more likely to achieve 
remission than cats that started with the standard insulin therapy (71% vs. 50%, 
respectively).  
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